Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Link
http://link.springer.com/content/pdf/10.1007/BF02220448.pdf
Reference17 articles.
1. Ward HWC: Anti-estrogen therapy for breast cancer: A trial of tamoxifen at two dose levels. Br Med J 1:13–14, 1973
2. Nayfield SG, Karp JF, Ford LG, Dorr FA, Kramer BS: Potential role of tamoxifen in prevention of breast cancer J Natl Cancer Inst 83:1450–1459, 1991
3. Fugh-Berman A, Epstein S: Tamoxifen: Disease prevention or disease substitution? Lancet 340:1143–1145, 1992
4. Raloff J: Tamoxifen quandary. Sci News 141:266–269, 1992
5. Noguchi M, Taniya T, Tajiri K, Miwa I, Miyazaki H, Koshino H, Mabuchi H, Nomura A: Fatal hyperlipidemia in case of metastatic breast cancer treated by tamoxifen. Br J Surg 74:586–587, 1987
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug-induced liver injury secondary to tamoxifen;BMJ Case Reports;2024-06
2. Microfluidic systems for drug discovery, pharmaceutical analysis, and diagnostic applications;Microfluidic Devices for Biomedical Applications;2021
3. Prevalence, incidence and risk factors of tamoxifen‐related non‐alcoholic fatty liver disease: A systematic review and meta‐analysis;Liver International;2020-04-07
4. Medikamentös-toxischer Leberschaden (DILI);Pathologie;2020
5. An Unusual Case of Acute Liver Failure Caused by Adjuvant Oral Tegafur-Uracil with Folinate Therapy for Colon Cancer Patient: a Case Report;Journal of Gastrointestinal Cancer;2019-03-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3